Generic Co. Gets Horizon's Painkiller Patent Partly Axed

By Tiffany Hu (December 1, 2020, 4:41 PM EST) -- Horizon was dealt a loss in its patent fight over the painkiller drug Duexis after a Delaware federal judge ruled that part of the drugmaker's patent is invalid and not infringed by Alkem Laboratories Ltd.'s planned generic version of the drug....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!